Commentary|Podcasts|January 20, 2025
Reaching Diverse Patient Populations With Personalized Treatment Methods
Author(s)Andy Studna, Senior Editor
Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses:
- Industry’s greatest challenges in reaching diverse patient populations
- Personalized treatment methods
- Recruitment strategies
- and more!
Related Content
Trending on Applied Clinical Trials Online
1
You've Been Spending Recruitment Money at the Wrong End of the Funnel
2
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
3
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial
4
ACT Brief: Real-Time Monitoring Through Quick Wins, Consumer Wearable Validation Requirements, and Replimune RP1 Efficacy Data Advancement
5